Programme and Presentations

UK & Ireland Prostate Brachytherapy Conference 2024

Portsmouth 25-26 April

Action Stations, HM Naval Base, Portsmouth, PO1 3LJ

    ABSTRACT SLIDES  
08:00 Registration (Tea & Coffee)      
08:30 Welcome/Opening     Dominic Hodgson / Cdre Paul Pitcher
Invited Speakers     Chair: Yoodhvir Nagar / Wojciech Polak
08:45 Preliminary results of LIBERATE – focal brachytherapy for low-to intermediate risk prostate cancer: QOL and early oncological outcomes Andrew See, Icon Group, Australia
09:10 Update on Prostate Brachytherapy Guidelines from the EAU Philip Cornford, Royal Liverpool and Broadgreen University Hospitals
09:35 Brachytherapy with SpaceOAR Roberto Alonzi, Mount Vernon
10:00 One-minute Poster Pitches Chair: Tony Palmer
  Outcomes for patients with prostate cancer treated with External beam radiotherapy with High dose rate brachytherapy (HDR) boost at the Dorset Cancer Centre Aun-Kyaw Sun, Ben Masters
  Comparison of pre and post implant LUTS with implant dosimetry to determine cause of increase in post implant complications Sara Hodkinson, Jennifer Beeby, Ben Medford
  Development of a commissioning protocol for micro silica bead thermo-luminescent dosimeters (TLDs) for use in high dose rate brachytherapy. William Hamblyn, Amani Chowdhury, Gerry Lowe, Peter Hoskin
  The impact of needle reconstruction uncertainties on TRUS prostate plan parameters Jennifer Wilson
  RTT-led follow-up using patient-reported outcome measures following HDR-brachytherapy for prostate cancer Sarah Stead, Lauren Oliver, Richard Walshaw, Chinnamani Eswar, Isabel Syndikus, R Hunter
  Development of a self TWOC service for out Brachytherapy service. Claire Johnson, Alice Gamble
  A Quality Improvement Project for prescribing for local anaesthetic trans-perineal prostate biopsies: outcomes from 944 patients. Tomas Austin, Joshuah Hill, Sean Pellow, Sally Deverill, Matt Crockett, Dominic Hodgson
  A 3D Printed Phantom for Training in Ultrasound Guided Prostate Brachytherapy Siobhan Gorman, Sreelish Kariyarambath, Peter Gribbin
  Environmental Sustainability in Brachytherapy: A UK study Gerry Lowe, Amanda Tate, Priya Narga‑Martin
  MRI registration with the Transrectal ultrasound in LDR Prostate Brachytherapy Prabakar Sukumar, Helen Winter
  Comparative analysis of pre-operative LDR Treatment Planning based on MRI and US prostate volume studies Inna O’Hea, Wojciech Polak, Sarah Wilby, Harry Gibbard
  Development of a Prostate Tissue Mimicking Material and Reusable Phantom for MRI Biopsy and Brachytherapy Sarah Wilby, Antony Palmer, Wojciech Polak
  Possibility of salvage re-irradiation of perineal prostate cancer nodule following prostate low dose rate brachytherapy (LDR-BT). Mark Long
  An analysis of LDR prostate brachytherapy outcomes in a single centre over 18 years Bowen J, Mirza S, Al-Eryani K, Berman B, O’Hea I, Hodgson D
10:15 Tea & Coffee/Exhibition and Poster Viewing
Proffered Presentations     Chair: Peter Hoskin/ Ann Henry
10:45 Can low dose rate brachytherapy be considered a treatment option for patients with prostate cancer with intermediate or high risk features? Rebecca Morgan, Poole General Hospital
10:55 QOL outcomes in patients receiving Low dose rate brachytherapy boost with EBRT for unfavourable intermediate and high risk prostate cancer: A single institution experience. Mansoor Qayoumi, Cork University Hospital
11:05 Analysis of Survival Following Low-Dose Rate Brachytherapy Boost for Prostate Cancer at the Royal Surrey Hospital: A Comparison with the Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (ASCENDE-RT) Trial Metawe Mohamed, Royal Surrey Hospital
11:15 HDR brachytherapy boost in Gleason 9-10 prostate cancer Heather Tovey, University Hospital of Leicester
11:25 High dose-rate salvage brachytherapy in prostate cancer with isolated seminal vesicle relapse Milan Anjanappa, Mount Vernon
11:35 Reirradiation Options for Previously Irradiated Prostate cancer (RO-PIP): Feasibility Study Investigating Toxicity Outcomes Following Reirradiation with Stereotactic Body Radiotherapy (SBRT) vs. High Dose-Rate Brachytherapy (HDR-BT) Jim Zhong, Leeds Cancer Centre
11:45 Using ProKnow to set up an inter Trust database of post implant dosimetry for prostate iodine-125 implants. Daniel Emmens, Maidstone & Tunbridge Wells
12:00 Lunch/Exhibition and Poster Viewing      
Debate Chair: Philip Cornford / Yoodhvir Nagar
13:00 SABR vs LDR brachytherapy   Julia Murray, Royal Marden, Ann Henry, Leeds Cancer Centre
Proffered Presentations     Chair: Dominic Hodgson / Sarah Wilby
13:45 Commissioning for HDR prostate Brachytherapy: Early Clinical Experience Rissa Cunningham, Guy’s and St. Thomas’
13:55 MRI-guided Needle Placement Robot for Prostate Brachytherapy Taimur Shah, Imperial College London
14:05 Innovative Approaches to Prostate Biopsy Decision-Making: A Machine Learning and Optimisation Framework Sara Saadatmand, University of Portsmouth
14:15 Predictive factors in US-MRI fusion prostate biopsy: a review of 2347 case. Harry Gibbard, Portsmouth
14:25 Tea & Coffee/Exhibition and Poster Viewing
Invited Speakers     Chair: Dominic Hodgson / Tony Palmer
14:55 ORIGIN: Optical fibre sensors for in vivo dosimetry   Sinead O’Keefe, University of Limerick
15:20 Salvage brachytherapy: do we have consensus?   Peter Hoskins, Mount Vernon & Christie Cancer Centre
15:45 Update on Prostate Biopsy Guidelines from the EAU Philip Cornford, Royal Liverpool and Broadgreen University Hospitals
16:00 Drug Loaded Spacers for LDR Prostate Brachytherapy Andrew Wang, UT Southwestern Medical Centre
16:25 Meeting Close and Handover Dominic Hodgson
< back to archive